当前位置:首页 - 行情中心 - 天康生物(002100) - 财务分析

天康生物

(002100)

  

流通市值:100.89亿  总市值:100.89亿
流通股本:13.65亿   总股本:13.65亿

天康生物(002100)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.05亿元,每股收益0.30元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益876747.72万元,未分配利润129784.06万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1681684.26万元,负债804936.53万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入13,610,370,203.128,846,725,199.54,180,253,944.2417,175,805,190.11
营业总成本13,098,483,091.048,435,393,584.634,012,088,136.816,479,483,378.21
其他经营收益
营业利润502,001,579.92403,950,602.49154,716,821.76631,109,922.65
利润总额515,393,523.15420,984,340.33172,533,576.51610,812,435.64
净利润504,865,088.26409,618,129.4171,441,542.03596,421,188.04
每股收益
其他综合收益42,755,441.21-25,190,790.19-41,188,202.22225,776.62
综合收益总额547,620,529.47384,427,339.21130,253,339.81596,646,964.66
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计9,405,897,554.038,776,473,163.5710,244,239,958.979,847,752,197.03
非流动资产:
非流动资产合计7,410,944,996.587,466,013,773.777,554,295,360.367,714,760,074.09
资产总计16,816,842,550.6116,242,486,937.3417,798,535,319.3317,562,512,271.12
流动负债:
流动负债合计5,434,542,104.085,543,641,728.366,700,619,328.216,494,865,978.89
非流动负债:
非流动负债合计2,614,823,227.262,095,205,873.482,448,092,689.212,548,093,652.4
负债合计8,049,365,331.347,638,847,601.849,148,712,017.429,042,959,631.29
所有者权益(或股东权益):
归属于母公司股东权益合计7,170,426,280.417,028,287,241.177,122,587,964.947,015,639,913.05
股东权益合计8,767,477,219.278,603,639,335.58,649,823,301.918,519,552,639.83
负债和股东权益合计16,816,842,550.6116,242,486,937.3417,798,535,319.3317,562,512,271.12
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计13,373,823,339.428,820,950,257.064,135,625,727.3818,713,785,052.92
经营活动现金流出小计11,023,244,308.917,201,924,795.74,011,581,301.0817,551,919,746.6
经营活动产生的现金流量净额2,350,579,030.511,619,025,461.36124,044,426.31,161,865,306.32
投资活动产生的现金流量:
投资活动现金流入小计686,699.99686,699.99055,443,797.19
投资活动现金流出小计243,060,965.55179,118,903.5172,139,359.2805,462,554.36
投资活动产生的现金流量净额-242,374,265.56-178,432,203.52-72,139,359.2-750,018,757.17
筹资活动产生的现金流量:
筹资活动现金流入小计3,416,687,240.221,270,987,240.221,180,253,285.96,863,173,242.4
筹资活动现金流出小计4,637,457,733.072,855,507,964.661,107,466,510.026,994,042,341.07
筹资活动产生的现金流量净额-1,220,770,492.85-1,584,520,724.4472,786,775.88-130,869,098.67
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额887,434,272.1-143,927,466.6124,691,842.98280,977,450.48
期末现金及现金等价物余额3,560,019,371.522,809,635,083.33,078,254,392.882,953,562,549.9
补充资料:
现金及现金等价物的净增加额--143,927,466.6-280,977,450.48
最新报告期:2025-11-06
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国信证券李瑞楠,江海航,鲁家瑞0.550.460.422025-11-06
兴业证券曹心蕊,纪宇泽0.330.550.762025-11-05
开源证券王高展,陈雪丽0.310.510.712025-10-31
太平洋程晓东0.430.720.682025-10-31
财通证券肖珮菁0.330.530.682025-10-30
TOP↑